Status:
UNKNOWN
Thrombin in Cardiac Surgery
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
McMaster University
Conditions:
Thrombin
Hemostatic Disorder
Eligibility:
All Genders
18+ years
Brief Summary
Coagulopathy, bleeding, and transfusion are common in cardiac surgical patients. Our collaborator has developed a novel point of care device that can be used to assess thrombin generation in real-time...
Detailed Description
This is a prospective observational cohort study of 200 cardiac surgical patients. Thrombin generation via our novel point of care thrombin generation assay as well as calibrated automated thrombograp...
Eligibility Criteria
Inclusion
- All adult patients (\> 18 years of age) undergoing cardiac surgery at Toronto General Hospital will be offered participation.
Exclusion
- Patients who are unable to consent to the study or who refuse participation will be excluded.
Key Trial Info
Start Date :
August 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04762576
Start Date
August 10 2022
End Date
January 1 2023
Last Update
November 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital - University Health Network
Toronto, Ontario, Canada, M5G 2C4